1. CTLA-4 directly inhibits osteoclast formation. Issue 11 (18th January 2008) Authors: Axmann, R; Herman, S; Zaiss, M; Franz, S; Polzer, K; Zwerina, J; Herrmann, M; Smolen, J; Schett, G Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ERK-activated kinase RSK2 protects against inflammatory arthritis-induced bone destruction by opposing the tumour necrosis factor α-mediated inhibition of bone formation. (9th March 2010) Authors: Böhm, C; Zaiss, M M; Axmann, R; Hess, A; Engelke, K; Kollias, G; Schett, G; David, J-P Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKα. Issue 5 (17th August 2007) Authors: Polzer, K; Soleiman, A; Baum, W; Axmann, R; Distler, J; Redlich, K; Kilian, A; Krönke, G; Schett, G; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 5(2008) Page Start: 602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗